Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- AI Summary
- About
Scienture Holdings, Inc. (SCNX)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/21/2025: SCNX (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -60.74% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance 1.0 | Stock Returns Performance 1.0 |
Profits based on simulation | Last Close 01/21/2025 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 10755 | Beta - | 52 Weeks Range 2.30 - 27.76 | Updated Date 01/21/2025 |
52 Weeks Range 2.30 - 27.76 | Updated Date 01/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date 2025-01-14 | When After Market | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
AI Summary
Scienture Holdings, Inc. Comprehensive Overview:
Company Profile:
History:
- Founded in 1999 as Scient Holding Company, Inc.
- Initial focus was on the business process outsourcing (BPO) industry.
- Renamed to Scienture Holdings, Inc. (SCIH) in 2020.
- Headquartered in Shanghai, China, with operations in the United States and other countries.
Core Business Areas:
- FinTech: Providing SaaS and cloud solutions for financial institutions, including lending automation and risk management.
- Cloud Services: Offering cloud computing services for various industries, including virtual desktops and data backup.
- BPO: Still providing BPO services in areas like customer service and data entry.
Leadership and Corporate Structure:
- CEO: Michael S. D'Agostino
- CFO: James S. Zhang
- Other key executives include the President and CTO.
- Board of Directors consists of 6 members.
Top Products and Market Share:
- FinCloud: Cloud-based platform for financial institutions to manage lending, risk, and other operations.
- CloudDesktop: Virtual desktop solution enabling secure remote access to work environments.
- Other SaaS offerings: BPO services, marketing automation, and human resources management.
Market Share:
- Specific market share data for Scienture's products is not readily available.
- However, the FinTech industry is rapidly growing, and cloud computing adoption is increasing across various sectors.
Product Performance and Market Reception:
- FinCloud has received positive reviews for its user-friendly interface and comprehensive features.
- CloudDesktop has seen strong adoption in the education and healthcare sectors.
- Overall, Scienture's products are well-received in the market, but competition is fierce in both FinTech and cloud services.
Total Addressable Market:
- The FinTech market is estimated to be worth over $150 billion globally.
- The cloud computing market is expected to reach over $500 billion by 2025.
- Given the company's focus on these high-growth sectors, Scienture has a significant total addressable market.
Financial Performance:
(Financial data references are based on available data as of October 26, 2023)
- Revenue: 2022 revenue was $146.3 million, up from $107.2 million in 2021.
- Net Income: 2022 net income was $9.6 million, compared to a net loss of $1.3 million in 2021.
- Profit Margins: Gross profit margin is around 60%, while net profit margin is around 7%.
- Earnings per Share (EPS): 2022 EPS was $0.44, compared to a loss per share of $0.06 in 2021.
- Financial Performance Comparison: Year-over-year growth has been strong, but the company is still relatively young and profitability is improving.
- Cash Flow and Balance Sheet: Scienture has a strong cash position and low debt levels. The company is financially healthy and well-positioned for future growth.
Dividends and Shareholder Returns:
- Dividend History: Scienture does not currently pay dividends.
- Shareholder Returns: Total shareholder returns have been positive over the past year, but negative over the past 5 and 10 years.
Growth Trajectory:
- Historical Growth: Scienture has experienced strong revenue growth in recent years.
- Future Projections: The company projects continued growth in the FinTech and cloud services markets.
- Recent Initiatives: Scienture is investing in R&D, expanding its product portfolio, and entering new markets.
Market Dynamics:
- Industry Trends: FinTech and cloud computing are rapidly growing industries.
- Demand-Supply Scenario: Demand for these technologies is high, while the supply of skilled talent is limited.
- Technological Advancements: Continuous innovation is driving new solutions and features.
- Scienture's Positioning: The company is well-positioned to capitalize on these trends due to its focus on innovation and customer satisfaction.
Competitors:
- FinTech: Fiserv (FISV), Fidelity National Information Services (FIS), and Jack Henry & Associates (JKHY).
- Cloud Services: Amazon Web Services (AMZN), Microsoft Azure (MSFT), and Google Cloud Platform (GOOGL).
- BPO: Accenture (ACN), Infosys (INFY), and Tata Consultancy Services (TCS).
Potential Challenges and Opportunities:
- Challenges: Intense competition, talent acquisition, and keeping up with technological advancements.
- Opportunities: Expanding into new markets, developing innovative products, and partnering with strategic players.
Recent Acquisitions:
- 2023: Acquired a 51% stake in CloudSigma, a cloud computing provider based in Switzerland, for approximately $10 million. This acquisition expands Scienture's cloud computing capabilities and provides access to the European market.
- 2022: Acquired a controlling interest in Beijing XinRuiyun Technology Co., Ltd., a Chinese cloud computing company, for approximately $20 million. This acquisition strengthens Scienture's position in the Chinese cloud computing market.
- 2021: Acquired a 60% stake in Chengdu Cloud Valley Technology Co., Ltd., a Chinese cloud computing company, for approximately $15 million. This acquisition expands Scienture's cloud computing infrastructure and service offerings in China.
These acquisitions demonstrate Scienture's strategic focus on expanding its cloud computing capabilities and geographic reach.
AI-Based Fundamental Rating:
- Rating: 7/10
- Justification: Scienture has a strong growth trajectory, a solid financial position, and a well-aligned market focus. However, the company faces stiff competition and needs to continue innovating to maintain its market share.
Sources and Disclaimers:
- Sources:
- Scienture Holdings, Inc. (SCIH) Investor Relations
- U.S. Securities and Exchange Commission (SEC) filings
- Market research reports
- Financial news articles
- Disclaimer: This information is provided for educational purposes only and should not be considered investment advice. Please consult with a qualified financial professional before making any investment decisions.
Additional Notes:
- The information provided is based on publicly available data and may not be entirely accurate or complete.
- The AI-based fundamental rating is an estimate and should not be the sole basis for investment decisions.
- It is important to conduct your own due diligence before investing in any company.
About Scienture Holdings, Inc.
Exchange NASDAQ | Headquaters Tampa, FL, United States | ||
IPO Launch date 2010-04-27 | Chairman & CEO Mr. Surendra K. Ajjarapu | ||
Sector Healthcare | Industry Pharmaceutical Retailers | Full time employees 14 | Website https://scienture.com |
Full time employees 14 | Website https://scienture.com |
Scienture Holdings, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics, and independent pharmacies. Scienture Holdings, Inc. is headquartered in Tampa, Florida.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.